Health ❯ Healthcare ❯ Patient Care

Oncology

Cancer Treatment Survival Rates Chemotherapy Treatment Outcomes Medication Access Support Networks Tumor Treatment Support Systems Hormone Receptor Positive Breast Cancer Bone Marrow Transplant

Revolution Medicines’ Pancreatic Cancer Drug Lands ASCO Plenary After Phase 3 Survival Gain

The result challenges the belief that RAS‑driven pancreatic tumors cannot be targeted.

Experimental Drug Elraglusib Extends Survival in Phase 2 Pancreatic Cancer Trial

Most Detailed Prostate Cancer Cell Atlas Yet Charts Earliest Disease Signals

EsSalud Secures Emergency Pemetrexed Supply to Restart Chemo for 79-Year-Old Patient

Watchdog Finds EsSalud Emergencies Still Short of Medicines, Equipment

Tecvayli Cuts Progression Risk 71% and Deaths 40% in Phase 3 Myeloma Trial

FDA Clears Padcev Plus Keytruda Regimens as Perioperative Option for Cisplatin-Ineligible Muscle-Invasive Bladder Cancer

Study Reveals How Dialysis-Linked Kidney Cancers Develop, Marking a Distinct Disease Pathway

Unimed do Brasil to Take Over Care for Unimed Ferj Beneficiaries on Dec. 1

Quitting After Cancer Diagnosis Linked to Higher Two-Year Survival, JNCCN Study Finds

FDA Approves J&J’s Inlexzo Bladder Drug-Delivery Device for BCG‑Unresponsive NMIBC

TAR-200 Clears Tumors in 82% of High-Risk Bladder Cancer Patients, Advances to FDA Priority Review

Third Fatal Cardiac Incident Hits Morelia Bus Terminal This Month

Celcuity’s Gedatolisib Combos Yield Up to 76% Progression-Free Survival Gain in Phase 3 Trial

Five-year data show one-time T-cell therapy extends survival in advanced melanoma

Next-Generation CAR-T Therapies Deliver Remission in T-Cell Cancers and Extend Survival in Gastric and Brain Tumors

New Triple-Drug Regimen Boosts Survival in PIK3CA-Mutant HR+ HER2- Breast Cancer

Groundbreaking Surgery at MHH Cures Previously Inoperable Liver Cancer

Gabapentin Shows Potential to Extend Survival in Glioblastoma Patients

New Radioactive Therapy Shrinks Glioblastoma Tumor by Half in NHS Trial